Dublin, April 11, 2019 (GLOBE NEWSWIRE) -- The "Tumor Ablation Market Size, Share & Trends Analysis Report By Treatment (Surgical, Percutaneous), By Technology (Cryoablation, IRE, MWA, RFA), By Application (Liver, Lung, Breast, Prostate), And Segment Forecasts, 2019 - 2026" report has been added to ResearchAndMarkets.com's offering.
The global tumor ablation market size is anticipated to reach USD 2.41 billion by 2026, according to this report. The market is estimated to witness a healthy CAGR of 11.12% during the forecast period.
Increasing cases of cancer across the globe is the key growth-driving factor for this market. About 13% of the population suffers from cancer each year, as per the statistics by the World Health Organization (WHO). Demand for minimally invasive procedures due to the benefits, such as less trauma, speedy recovery, along with technological advancements in the field of thermal ablation is also likely to boost market growth.
For instance, usage of cooled radiofrequency denervation technique - a procedure that uses radiofrequency thermal energy to ablate sensory nerve fibers of the sacroiliac joint - with internally cooled radiofrequency probes to enlarge the lesion size. In February 2015, SonaCare Medical LLC launched Sonalink - a remote patient monitoring platform - that can be used during High-Intensity Focused Ultrasound (HIFU) procedures.
In addition, increasing per capita income is enabling people to take up advanced treatment for tumors, thus driving the growth of this market. Active role of healthcare agencies and government in creating awareness about various cancer types is also expected to facilitate usage of tumor ablation therapy, thereby supporting market development. For instance, September is declared as National Prostate Cancer Awareness Month in U.S., to spread awareness about the disease.
Further key findings from the study suggest:
- Radiofrequency led the technology segment in 2018 accounting for more than 25% of the global market share as this therapy finds applications in solid tumor removal
- Percutaneous procedures are expected to witness lucrative growth over the forecast period due to rising demand for minimally invasive procedures offering faster recovery and higher safety
- Lung cancer is anticipated to witness lucrative growth over the forecast period. Sedentary lifestyle, increasing incidences of smoking and rising air pollution are contributing to the growing prevalence of lung cancer
- North America led the overall tumor ablation market. Key factors driving the regional market are increasing prevalence of cancer, easy reimbursement policies, and availability of quality healthcare in the region
- Major companies in the market include Galil Medical, Inc.; Misonix, Inc.; HealthTronics, Angiodynamics, (Covidien), Boston Scientific Corporation; Medtronic Plc; SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical, Inc.
Key Topics Covered
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Information Procurement
1.3. Information Analysis
1.4. Market Formulation & Data Visualization
1.5. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Tumor Ablation Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. User Perspective Analysis
3.5. Regulatory Framework
3.6. Market Dynamics
3.7. Tumor Ablation: Market Analysis Tools
Chapter 4. Tumor Ablation Market: Segment Analysis, by Treatment, 2015 - 2026 (Usd Million)
4.1. Definitions & Scope
4.2. Treatment Type Market Share Analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Tumor Ablation Market, by Treatment, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Following
Chapter 5. Tumor Ablation Market: Segment Analysis, by Technology, 2015 - 2026 (Usd Million)
5.1. Definitions & Scope
5.2. Technology Type Market Share Analysis, 2018 & 2026
5.3. Segment Dashboard
5.4. Global Tumor Ablation Market, by Technology, 2015 to 2026
5.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Following
Chapter 6. Tumor Ablation Market: Segment Analysis, by Application, 2015 - 2026 (Usd Million)
6.1. Definitions & Scope
6.2. Application Type Market Share Analysis, 2018 & 2026
6.3. Segment Dashboard
6.4. Global Tumor Ablation Market, by Application, 2015 to 2026
6.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Following
Chapter 7. Tumor Ablation Market: Regional Market Analysis,2015 - 2026 (Usd Million)
7.1. Definitions & Scope
7.2. Regional Market Share Analysis, 2018 & 2026
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot (Market Size, Cagr, Top Verticals, Key Players, Top Trends)
7.5. Regional Market Share and Leading Players, 2018
7.6. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.7. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2026:
7.8. North America
7.9. Europe
7.10. Asia Pacific
7.11. Latin America
7.12. Middle East and Africa
Chapter 8. Tumor Ablation Market - Competitive Analysis
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
8.3. Vendor Landscape
8.4. Supplier Ranking
8.5. Key Companies Profiled
- Medtronic
- AngioDynamics
- Mermaid Medical
- HealthTronics Inc.
- Galil Medical Inc.
- EDAP TMS
- Boston Scientific Corporation
- SonaCare Medical LLC
- Misonix Inc.
- NeuWave Medical Inc.
- ERBE Elektromedizin GmbH
- Biotronik
For more information about this report visit https://www.researchandmarkets.com/r/2k5hci